OFM
KRON

Omega Fund Management’s Kronos Bio KRON Stock Holding History

Omega Fund Management’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-955,866
Closed -$1.24M – 12
2024
Q1 		$1.24M Sell
955,866
-2,862,417
-75% -$3.26M 0.8% 11
2023
Q4 		$4.77M Hold
3,818,283
– – 3.87% 7
2023
Q3 		$4.96M Hold
3,818,283
– – 4.56% 5
2023
Q2 		$6.57M Hold
3,818,283
– – 3.68% 7
2023
Q1 		$5.57M Hold
3,818,283
– – 3.64% 7
2022
Q4 		$6.19M Hold
3,818,283
– – 2.08% 7
2022
Q3 		$12.8M Hold
3,818,283
– – 4.68% 8
2022
Q2 		$13.9M Hold
3,818,283
– – 4.44% 7
2022
Q1 		$27.6M Hold
3,818,283
– – 5.65% 5
2021
Q4 		$51.9M Hold
3,818,283
– – 7.34% 5
2021
Q3 		$80M Hold
3,818,283
– – 8.98% 3
2021
Q2 		$91.4M Hold
3,818,283
– – 10.35% 4
2021
Q1 		$112M Hold
3,818,283
– – 10.57% 4
2020
Q4 		$114M Buy
+3,818,283
New +$120M 17.1% 2

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Omega Fund Management's KRON Position: Q2 2024 in Review

Omega Fund Management sold out of Kronos Bio (KRON) in Q2 2024, closing a stake of 955,866 shares — an estimated $1.24M sold.

Omega Fund Management first reported a position in KRON in Q4 2020 and held it in 14 quarters. The position peaked at $114M in Q4 2020. 56 funds tracked by Wall St. Rank hold KRON as of Q2 2024.

  • Omega Fund Management reported no remaining Kronos Bio position as of Q2 2024 after selling out during the quarter.
  • Omega Fund Management sold 955,866 Kronos Bio shares in Q2 2024, an estimated $1.24M.
  • Omega Fund Management first reported a position in Kronos Bio in Q4 2020 and held it in 14 quarters.
  • Omega Fund Management's Kronos Bio position peaked at $114M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2024.

Based on Omega Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.